Cannabis Research
THCV: The Fusion of Two 21st Century Billion Dollar Industries
Add MyCannabis.com to your preferred sources on Google
THCV’s weight loss potential is sparking interest across two booming markets: the multi-billion-dollar weight loss industry and the fast-growing cannabis sector. Weight loss alone has Americans spending more than $33 billion annually on products and services. In 2021, the global weight loss market was valued at about $250 billion, while the legal cannabis industry stood at $13 billion and is projected to approach the $100 billion mark in the coming years. The question now is whether tetrahydrocannabivarin (THCV) could connect these industries and drive further growth.
To understand why THCV is generating attention, it helps to compare its characteristics with THC, the most well-known cannabinoid:
Swipe to scroll →
| Property | THC | THCV |
|---|---|---|
| Psychoactivity | Psychoactive, produces a “high” | Non-psychoactive at low doses; may offset THC effects |
| Appetite Effect | Stimulates appetite (“munchies”) | Suppresses appetite |
| Metabolism Impact | Minimal effect on metabolism | May increase energy metabolism |
| Action at CB1 Receptor | Agonist (activates receptor) | Antagonist (blocks/reduces activation) |
| Potential Medical Use | Pain relief, nausea reduction, and appetite stimulation | Weight management, diabetes research, metabolic support |
THCV is one of the many phytocannabinoids found in Cannabis sativa. While structurally similar to THC, it has notable differences.
Unlike THC, THCV does not typically produce psychoactive effects. Some anecdotal reports even suggest that, like CBD, THCV may counter certain intoxicating effects of THC. Another key difference is its influence on appetite. While THC often stimulates hunger, THCV appears to suppress it and may boost energy metabolism, earning it the nickname “diet weed.”
Study Links THCV to Weight Loss
A review1 published in the Journal of Cannabis Research in January 2020 examined the potential of THCV in managing obesity and diabetes.
The research was a systematic review of peer-reviewed literature from 1970 to 2019, using the following keywords:
- THCV
- THC
- Cannabis sativa (marijuana)
- Obesity
- Body weight
- Metabolism
- Diabetes
Rodent studies indicated that THCV reduced appetite and increased feelings of fullness. It was generally well tolerated, particularly when administered with CBD. These findings highlight THCV’s potential as a therapeutic tool in weight management, although human clinical trials are still limited.
Action at the CB1 Receptor
While THC acts as an agonist at the CB1 receptor, THCV functions primarily as an antagonist. This means it interacts with the receptor in a way that reduces activity rather than stimulating it. In studies, THCV suppressed appetite in both fasted and non-fasted mice, supporting its potential role in obesity treatment. Researchers emphasize the need for further human trials to confirm these effects and establish optimal dosing.
Pairing Cannabis with Weight Loss
The possibility of combining cannabis science with weight management strategies has not gone unnoticed by major pharmaceutical players. In 2022, Pfizer (PFE ) acquired Arena Pharmaceuticals for $6.7 billion. Arena has been developing Olorinab, a cannabinoid-based investigational drug for irritable bowel syndrome. Additionally, companies such as HW Pharmaceuticals have filed over 100 cannabis-related patents, signaling strong interest in the therapeutic potential of cannabinoids like THCV.
With both the cannabis and weight loss industries valued in the billions and on upward growth paths, the potential intersection is drawing attention. If research confirms that THCV is safe and effective for weight management, it could represent a lucrative and transformative development for both markets.
References:
1. Abioye, A., Ayodele, O., Marinkovic, A. et al. Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes. J Cannabis Res 2, 6 (2020). https://doi.org/10.1186/s42238-020-0016-7
